The Cancer Letter

Inside information on cancer research and drug development

Vol.
32
No.
1
January 13, 2006Jan 13, 2006
Free
DOWNLOAD THE PDF

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

NCI Establishes New Program Project Grant Guidelines.

Chemotherapy Pioneer Howard Skipper Dead; His Work With Lekemia Cells In Mice Led To Development of Combination Therapies.

Login

Looking for IP Login?